Jones Trading Starts AbCellera Biologics (ABCL) at Buy

Jones Trading analyst Debanjana Chatterjee initiates coverage on AbCellera Biologics (NASDAQ: ABCL) with a Buy rating and a price target of $11.00.

For an analyst ratings summary and ratings history on AbCellera Biologics click here. For more ratings news on AbCellera Biologics click here.

Shares of AbCellera Biologics closed at $3.43 yesterday.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%